High antioxidative potential and low toxic effects of selenosemicarbazone metal complexes

Novel metal-based compounds with therapeutic potential became the subject of intense investigation in inorganic chemistry and biomedical science. Recently, strong dose-dependent cytotoxic activity against several human cancer cell lines of selenosemicarbazone metal complexes was demonstrated. The ai...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Serbian Chemical Society Vol. 78; no. 10; pp. 1503 - 1512
Main Authors Dekanski, Dragana, Todorovic, Tamara, Mitic, Dragana, Filipovic, Nenad, Polovic, Natalija, Andjelkovic, Katarina
Format Journal Article
LanguageEnglish
Published Belgrade Journal of the Serbian Chemical Society 2013
Serbian Chemical Society
Subjects
Online AccessGet full text
ISSN0352-5139
1820-7421
DOI10.2298/JSC130315035D

Cover

More Information
Summary:Novel metal-based compounds with therapeutic potential became the subject of intense investigation in inorganic chemistry and biomedical science. Recently, strong dose-dependent cytotoxic activity against several human cancer cell lines of selenosemicarbazone metal complexes was demonstrated. The aim of the present study was to investigate in vitro antioxidative potential of Ni(II), Cd(II) and Zn(II) selenosemicarbazone complexes. All three investigated complexes exhibited high ABTS radical scavenging capacity, comparable with ascorbic acid. In the acute toxicity study, administration of the compounds was performed orally to the mice at the single doses and they were observed for clinical signs, body weight effects, and mortality for 14 days after which they were sacrificed for gross organ necropsy. Body weight did not vary after administration, and the autoptic analysis failed to show appreciable macroscopic alterations of internal organs. Generally, the compounds exhibited low toxic effects as required for further in vivo therapeutic studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0352-5139
1820-7421
DOI:10.2298/JSC130315035D